Abstract
Escherichia coli TAP (thioesterase I, EC 3.1.2.2) is a multifunctional enzyme with thioesterase, esterase, arylesterase, protease and lysophospholipase activities. Previous crystal structural analyses identified its essential amino acid residues as those that form a catalytic triad (Ser10-Asp154-His157) and those involved in forming an oxyanion hole (Ser10-Gly44-Asn73). To gain an insight into the biochemical roles of each residue, site-directed mutagenesis was employed to mutate these residues to alanine, and enzyme kinetic studies were conducted using esterase, thioesterase and amino-acid-derived substrates. Of the residues, His157 is the most important, as it plays a vital role in the catalytic triad, and may also play a role in stabilizing oxyanion conformation. Ser10 also plays a very important role, although the small residual activity of the S10A variant suggests that a water molecule may act as a poor substitute. The water molecule could possibly be endowed with the nucleophilic-attacking character by His157 hydrogen-bonding. Asp154 is not as essential compared with the other two residues in the triad. It is close to the entrance of the substrate tunnel, therefore it predominantly affects substrate accessibility. Gly44 plays a role in stabilizing the oxyanion intermediate and additionally in acyl-enzyme-intermediate transformation. N73A had the highest residual enzyme activity among all the mutants, which indicates that Asn73 is not as essential as the other mutated residues. The role of Asn73 is proposed to be involved in a loop75–80 switch-move motion, which is essential for the accommodation of substrates with longer acyl-chain lengths.
Keywords: catalytic triad, enzyme kinetics, esterase, oxyanion hole, site-directed mutagenesis, thioesterase I (TAP)
Abbreviations: C12-CoA, lauroyl-CoA; DEP, diethyl p-nitrophenyl phosphate; IPTG, isopropyl β-D-thiogalactoside; LB, Luria–Bertani; L-NBTNPE, N-carbobenzoxy-L-tyrosine p-nitrophenyl ester; Ni-NTA, Ni2+-nitrilotriacetate; NPB, p-nitrophenyl butyrate; TAP, thioesterase I; TAP-OCA, native TAP soaked with octanoic acid
INTRODUCTION
Lipases and esterases are widely distributed in Nature and they also have multifunctional activities in industrial applications such as the hydrolysis of lipids, the synthesis of esters, thioesters and amides, and the kinetic resolution of racemic mixtures [1,2]. Through protein database mining, Upton and Buckley [3] generalized a lipolytic family with diverse substrate specificity that contain a GDSLS motif (with the active-centre serine located near the N-terminus) and five consensus blocks with homologous amino-acid-sequence arrangement (shown in Figure 1). Previously, a subgroup of the GDSL family, derived from the aforementioned lipolytic family, was classified further as SGNH-hydrolases due to the presence of four strictly conserved residues, Ser-Gly-Asn-His, in the four conserved blocks I, II, III, and V respectively (Figure 1) [4,5]. We have also reviewed a number of enzymes in the GDSL family, which show a broad range of substrate specificies [6].
Our group was the first to report on the arylesterase (EC 3.1.1.2) from Vibrio mimicus [7,8] and the multiple functions of thio-esterase I/protease I from Escherichia coli [9,10]. Both proteins belong to the GDSLS family and show a 51.7% sequence similarity [7]. TAP (thioesterase I, EC 3.1.2.2) consists of 182 amino acid residues, with a molecular mass of 20.5 kDa [11]. It specifically catalyses the deacylation of fatty acyl-CoA thioesters from fatty acyl-acyl carrier proteins, especially those with long acyl groups (C12–C18). Since several different names – including thioesterase I, protease I, and lysophospholipase L1 – have been used in the literature for the versatile activities of the protein, the gene product was designated TAP, on the basis of the chronological order of the discovery of the gene (TesA/ApeA/PldC) [11–18]. In previous studies, the secondary structure was solved using NMR [19,20] and X-ray crystallography [21,22]. These two methods illustrated slight structural differences that are shown in Figure 1. NMR analyses indicated that TAP consists of a four-strand parallel β-sheet and seven α-helices (Figure 1), with a folding topology of an α/β/α type. TAP forms a tetramer at pH values above 6.5, while existing as a monomer at lower pH values [19]. Both monomeric and tetrameric forms were shown to be catalytically active at a pH greater than 5.0 [10]. The crystallographic structure of TAP (PDB code 1IVN) with 1.95 Å resolution (1 Å=0.1 nm) has further identified Ser10, Asp154 and His157 as the residues that form the catalytic triad [21], and another two conserved residues Gly44 and Asn73 (in SGNH) [22]. The secondary structure deposited into the PDB consists of five β-strands and 11 helices, made up of seven α-helices and four 310-helices (Figure 1). The crystal co-ordinates were plotted using the ViewerLite (version 5.0, Academic Version; Accelrys Inc.) program, and show a similar secondary structure (Figure 2), with only minor differences compared with the structure of the reported crystal protein (presented in Figure 1).
In the present study, several residues related to the catalytic activity of TAP were mutated to alanine by site-directed mutagenesis. The enzymatic activities of the mutants were analysed using three different substrates: NPB (p-nitrophenyl butyrate), which represents a simple ester, for use in the esterase activity assay; C12-CoA (lauroyl-CoA), which represents a medium acyl-chain-length thioester, for use in the thioesterase activity assay, and; L-NBTNPE (N-carbobenzoxy-L-tyrosine p-nitrophenyl ester), which represents an aromatic amino-acid-derived ester substrate. The kinetic parameters of the mutants provide direct information on substrate binding affinity (Km) and catalytic efficiency (kcat/Km). Combined with the protein structures revealed by NMR and crystallography, these results have provided insights into the structure and essential residues of one member of the GDSL- and SGNH-hydrolase families.
EXPERIMENTAL
Materials
Oligonucleotide primers were made by DNAFax Co. (Taipei, Taiwan, Republic of China). Taq DNA polymerase and DNA sequencing kit were obtained from HT Biotechnology Ltd (Cambridge, U.K.) and US Biochemicals (Cleveland, OH, U.S.A.) respectively. IPTG (isopropyl β-D-thiogalactoside) was obtained from Boehringer Mannheim Biochemicals. Substrates of NPB, C12-CoA and L-NBTNPE were purchased from Sigma. Restriction enzymes were purchased from Promega Biosciences. Ni-NTA (Ni2+-nitrilotriacetate) resin (His6-binding resin) was purchased from Novagene. Protein molecular-mass markers were purchased from Novex.
Construction of the wild-type TAP gene in E. coli
The recombinant TAP gene with a His6-tag coding sequence fused to the 3′-end, was designated as ‘wild-type’ and was synthesized from a plasmid containing the tesA gene [11] by PCR [7]. The 5′-end of the forward primer (5′-GAAGGAGATATACA-TATGGCGGACACGTTA-3′) and 3′-end of the reverse primer (5′-GTGGTGGTGCTCGAGTGAGTCATGATTTAC-3′) were designed to introduce sites for digestion by the restriction enzymes NdeI and XhoI respectively (the restriction enzyme sites are underlined in the primers). After restriction enzyme digestion, the PCR products were ligated into the pET 20b(+) vector (Novagene), which had been linearized using NdeI and XhoI. To obtain the constructed plasmid, it was transformed into E. coli DH5α cells (Promega Biosciences). The sequence of the recombinant gene was confirmed by full-length DNA sequencing. The verified plasmid was transformed into E. coli BL21(DE3) cells (Novagene) for target gene overexpression.
Site-directed mutagenesis
The catalytic-triad residues, Ser10-Asp154-His157, as well as the oxyanion-related residues, Gly44 and Asn73, were mutated to alanine. The mutagenesis was carried out by overlap-extension PCR, which consisted of two stages [8]. The first PCR stage simultaneously generates two PCR fragments: the first used a 5′-forward primer and a 3′-reverse primer that contains the mutation, the other used a 5′-forward primer that contains the mutation and a 3′-reverse primer. The second stage was carried out using the wild-type gene as the template, to which both PCR products from the first stage could anneal. The extension was performed between the 5′-end forward and 3′-end reverse primers. The PCR primers designed for site-directed mutagenesis are summarized in Table 1 (only the sense sequences are listed, and the corresponding mutation primers are the antisense sequences). A plasmid preparation kit (Qiagen) was used to purify the PCR products by following the agarose-gel-extraction method. The mutant genes were then subcloned and sequenced in the same manner as the aforementioned wild-type gene.
Table 1. Synthetic oligonucleotides used in site-directed mutagenesis.
Oligonucleotide sequence 5′→3′ | Restriction site | Mutant |
---|---|---|
GAT ATA CAT ATG GCG GAC ACG TTA TTG ATT CTG GGT GAT GCG CTG AGC | NdeI | S10A |
AAG CCA CAA TGG ATG CAG GAT GCG GGT ATT | D154A | |
GAC GGT ATT GCG CCC AAC CGC | H157A | |
AAT GCC AGC ATC AGC GCG GAC ACC TCG CAA | G44A | |
GAA CTG GGC GGC GCG GAC GGT TTG CGT GGT | N73A |
Cell growth, protein expression and purification
E. coli BL21(DE3) cells transformed with the desired plasmid were grown at 37 °C with 200 rev./min orbital shaking in LB (Luria–Bertani) broth containing 1% (w/v) Bacto tryptone, 0.5% (w/v) Bacto yeast extract and 1% (w/v) NaCl, pH 7.0. For plasmid selection, ampicillin was added to a final concentration of 50 μg/ml. After the bacteria reached a D600 of approx. 0.6, protein overexpression was induced by the addition of IPTG (to a final concentration of 0.4 mM) and cells were incubated at 30 °C for a further 4 h. The cells were harvested by centrifugation (at 17300 g for 10 min) and the cell pellet (from 100 ml of LB broth culture) was resuspended in 40 ml of Ni-NTA resin-binding buffer (5 mM imidazole, 0.5 M NaCl and 20 mM Tris/HCl, pH 7.9) and then frozen at −70 °C for 20 min. After thawing, the suspension was sonicated using an XL-2020 sonicator (Misonix Co.) for 10 pulses of 30 s, with an interval of 30 s, at a setting of approx. 137.5 W, and then centrifuged at 17300 g for 20 min at 4 °C. The supernatant containing His6-tagged TAP protein was purified by affinity chromatography using Ni-NTA resin as described previously [10]. The proteins that specifically bound to the column were eluted with 250 mM imidazole. Protein purity was monitored by SDS/PAGE (see below for details), and the protein was dialysed against 25 mM sodium phosphate buffer, pH 7.0.
SDS/PAGE, Coomassie Brilliant Blue staining and esterase-activity stain of wild-type TAP and mutants
Proteins were analysed by SDS/PAGE [15% (w/v) gels and 1% (w/v) SDS]. Protein samples were prepared by the addition of an equal volume of SDS/PAGE loading dye [2% (w/v) SDS, 200 mM dithiothreitol and 100 mM Tris/HCl, pH 6.8], boiled for 5 min, and then held on ice for 10 min before loading. Each sample was subjected to SDS/PAGE on two separate gels: one was stained with Coomassie Brilliant Blue to analyse protein purity and the other was used for esterase-activity staining, as described previously [23]. Before activity staining, the SDS in the gel was removed by washing twice with 25% (v/v) propan-2-ol for 30 min each. The gel was then washed in 0.1 M sodium phosphate buffer, pH 7.0, for a further 30 min [24].
Enzyme kinetic studies of wild-type TAP and mutants
The purified proteins were used for kinetic studies at 37 °C, and all the enzyme activities were determined using spectrophotometry. For simple ester substrate analysis, five concentrations (0.5, 1.0, 1.5, 2.0 and 2.5 mM) of NPB were prepared in 50 mM sodium phosphate buffer, pH 7.0, containing 2.1% (v/v) Triton X-100. The increase in A405 was recorded for 10 min, which was then converted into the production of p-nitrophenol per min for initial rate determination [8]. The molar absorption coefficient of p-nitrophenol was calculated (ϵ405=1725 M−1·cm−1). For the thioesterase activity assay, six concentrations (25, 50, 75, 100, 150 and 200 mM) of C12-CoA were prepared in 0.1 mM DTNB [5,5′-dithiobis-(2-nitrobenzoic acid)], 80 μg/ml BSA and 50 mM potassium phosphate buffer, pH 7.0 [11]. The activity was monitored for 2–6 min and the molar absorption coefficient was calculated (ϵ412=13600 M−1·cm−1). For the amino-acid-derived substrate, 2 mM L-NBTNPE was dissolved in 1 ml of dioxane, which was subsequently diluted with 0.1 M sodium phosphate buffer, pH 7.5, to the desired concentrations (25, 50, 75, 100, 150 and 200 mM); the molar absorption coefficient was calculated (ϵ400=3454 M−1·cm−1) [17]. The values of Km and kcat (kinetic parameters) and means±S.D. were calculated from three independent experiments by non-linear regression and were plotted using the Michaelis–Menten equation.
RESULTS AND DISCUSSION
Generation and purification of wild-type TAP and mutant enzymes
After subcloning, the mutations in the TAP gene were verified by DNA sequencing. The genes were overexpressed in E. coli BL21(DE3) cells, and the products were purified to homogeneity, which was shown by Coomassie Brilliant Blue staining of SDS/PAGE gels (Figure 3A). The activity staining of mutants S10A and H157A clearly showed that they had lost hydrolysis activity in response to the substrate α-naphthyl butyrate (Figure 3B). Nevertheless, G44A, N73A and D154A retained weak activity in response to the substrate, of which, N73A had the highest residual activity that was consistent with the results of the kinetic studies (Table 2).
Table 2. Kinetic analysis of wild-type and mutants of TAP.
Substrate | Parameter | Wild-type | S10A | D154A | H157A | G44A | N73A |
---|---|---|---|---|---|---|---|
NPB | kcat (s−1) | 15.29±0.79 | 0.16±0.01 | 5.98±0.59 | 0.0093±0.0007 | 3.16±0.08 | 11.99±2.13 |
(1.0%) | (39%) | (0.06%) | (21%) | (78%) | |||
Km (mM) | 0.87±0.13 | 1.55±0.18 | 1.88±0.37 | 0.61±0.18 | 1.10±0.14 | 1.66±0.35 | |
(1.78-fold) | (2.16-fold) | (0.70-fold) | (1.26-fold) | (1.91-fold) | |||
kcat/Km | 17.75 (100%) | 0.10 (0.57%) | 3.18 (18%) | 0.015 (0.09%) | 2.87 (16%) | 7.22 (41%) | |
C12-CoA | kcat (s−1) | 10.13±0.87 | 0.057±0.007 | 0.45±0.01 | ND | 0.77±0.04 | 1.14±0.08 |
(0.6%) | (4%) | (7.6%) | (11.3%) | ||||
Km (mM) | 0.146±0.022 | 0.127±0.028 | 0.059±0.005 | ND | 0.075±0.008 | 0.085±0.016 | |
(0.87-fold) | (0.40-fold) | (0.51-fold) | (0.58-fold) | ||||
kcat/Km | 69.44 (100%) | 0.45 (0.6%) | 7.62 (11%) | ND | 10.19 (15%) | 13.35 (19%) | |
L-NBTNPE | kcat (s−1) | 88.99±3.97 | 0.02±0.00 | 6.44±0.28 | ND | 7.71±0.21 | 7.81±0.09 |
(0.02%) | (7.2%) | (8.7%) | (8.8%) | ||||
Km (mM) | 0.174±0.014 | 0.061±0.010 | 0.043±0.007 | ND | 0.060±0.005 | 0.044±0.002 | |
(0.35-fold) | (0.25-fold) | (0.34-fold) | (0.25-fold) | ||||
kcat/Km | 512.40 (100%) | 0.32 (0.06%) | 149.64 (29%) | ND | 127.94 (25%) | 178.86 (35%) |
Role of the residues of the catalytic triad and their catalytic parameters
According to the crystallographic structure of the TAP protein, the residues that consist of the catalytic triad, Ser10-His157-Asp154, are lined up in a row on one side of the active-site cleft, with Ser10 taking the innermost position in the cleft, and Asp154 found nearest the surface of the protein (Figure 2). Figure 4 shows that the distance between Oγ of Ser10 and Nϵ2 of His157 is 3.02 Å, and Oδ2 and Oδ1 of Asp154 are close to Nδ1 and the amide-N of His157 with distances of 2.78 and 2.98 Å respectively. When the histidine Nϵ2 of the imidazole ring is deprotonated, the three residues in the catalytic triad can co-ordinate each other by hydrogenbonding, (Ser10)Oγ-H···Nϵ2(His157)Nδ1-H···Oδ2=C(Asp154). Hydrogen-bonding between the amide-N of His157 and the Oδ1 of Asp154 could also presumably strengthen the co-ordination (Figure 4).
In the esterase-activity assay, the kcat/Km of mutants S10A, D154A and H157A were reduced to 0.57, 18 and 0.09% respectively. Mutant H157A showed very low activity, which was measured by the addition of a large amount of enzyme, combined with a prolonged reaction time. Therefore this mutant was omitted for the other two enzymatic assays. His157 obviously plays the most important role in the catalytic triad by acting as a connector between Ser10 and Asp154. For mutants S10A and D154A, all three substrates were used to monitor their catalytic parameters.
S10A
For direct targeting of the catalytic serine residue, Ser10, the crystal structure of TAP enzyme covalently bound to the serine-enzyme inhibitor DEP (diethyl p-nitrophenyl phosphate) was solved (PDB code 1J00) (Figure 5) [25]. The covalent bond between Ser10 Oγ and the phosphorus of the DEP molecule indicated that Ser10 is devoted to nucleophilic attack on the carbonyl-C of an ester bond in a regular catalysis reaction. The Nϵ2 of His157 formed hydrogen bonds with the phosphorus oxygen of DEP and no longer interacted with the catalytic Ser10. The corresponding positions of His157 and Asp154 remained in the same conformation as the wild-type TAP structure (Figure 4). When NPB was used as the enzyme substrate, the mutant S10A gave a Km value that was approx. 2-fold greater than that of the wild-type and a kcat value that was only 1.0% of the wild-type (Table 2). When C12-CoA was used as the substrate, the mutant retained 0.6% of the kcat value (compared with the wild-type) and had a similar Km value. The weak activity of S10A suggests that a water molecule in the active centre [26] could replace the hydroxy group of Ser10 to attack the carbonyl-C of ester, and that the water molecule could be activated by His157, which serves as proton acceptor, although through a much slower catalytic mechanism. When catalysing L-NBTNPE, S10A acted even more weakly, with only 0.02% of the kcat activity compared with the wild-type. However, the Km value was reduced to approx. one-third of the wild-type. The lower Km perhaps indicates that the higher hydrophobic active centre of S10A is more accessible to L-NBTNPE, a more hydrophobic substrate. It could also be assumed that L-NBTNPE may interfere in the proper positioning of a water molecule in the formation of the hydroxy-L-NBTNPE tetrahedral intermediate.
D154A
In the three enzymatic assays, D154A retained 18, 11 and 29% of its catalytic efficiency compared with the wild-type in response to the substrates NPB, C12-CoA and L-NBTNPE respectively, which suggests that Asp154 is not essential for catalysis. Asp154 is positioned close to the entrance of the substrate tunnel on the protein surface (Figure 2), therefore it could significantly affect enzymatic activity by altering substrate accessibility. Of the three substrates, NPB is the most hydrophilic and, as a result, had an increased Km value of 1.88±0.37 mM (an approx. 2-fold increase compared with the wild-type). However, decreased Km values were observed for the substrates C12-CoA and L-NBTNPE (40 and 25% of the wild-type respectively), which are themselves hydrophobic compounds. These observations are consistent with the expected effect of replacing an aspartic acid residue with the more hydrophobic alanine residue. Therefore the reduced catalytic efficiency was a result of significantly lower kcat values. In response to NPB, the mutant retained 39% of the kcat value compared with the wild-type. In addition to the hydrophobic effect, molecular size is an important distinction between the three substrates. The difference between the reduced kcat values for C12-CoA and L-NBTNPE (4 and 7.2% compared with the wild-type respectively) and the less-affected kcat value for NPB could, in part, result from the larger size of the C12-CoA and L-NBTNPE substrates compared with NPB. Oδ2-Asp154 attracts the proton of Nδ1-His157 (Figure 4), which could draw His157 backwards to provide a larger space during substrate binding. The methyl side-chain of D154A is presumed to not only weaken the hydrogen-bonding link between the residues of the catalytic triad, but also to diminish the His157 spanning area, which is consistent with the observed decline in kcat values in response to the two larger substrates, C12-CoA and L-NBTNPE.
H157A
For NPB substrate, H157A had similar Km value (0.61±0.18 mM) compared with the wild-type (0.87±0.13 mM); however, it had a dramatically reduced kcat/Km value (0.09% of the wild-type). This indicates that, without the hydrogen-bonding between the side chains of His157 and Ser10, the ester substrate retains approximate accessibility to the active cleft, and thus the barely detectable catalytic efficiency resulted from the extremely low kcat value (0.0093±0.0007 s−1) of the mutant. H157A had only 5.8% of the kcat activity of the S10A mutant, which supposedly performed catalysis aided by a water molecule in the active cleft. The crystal data of the TAP–DEP complex showed that the Nϵ2 of His157 interplayed with the inhibitor DEP (Figure 5) therefore His157 could probably stabilize the acyl–enzyme intermediate during the catalytic process. We conclude that His157 is the most important residue in the catalytic triad, as it is responsible for the activation of the catalytic serine, and also for its contribution to the hydrogen-bonding of the acyl–enzyme intermediate in the catalysis machinery.
Mutation of the residues involved in the oxyanion hole
Oxyanion is formed when Ser10-OγH attacks ester carbonyl-C, whose covalent π electron pair shifts on to the carbonyl-O. The oxyanion is so unstable that the DEP molecule covalently bound to TAP mimics the untraceable enzyme–substrate-intermediate [25]. The NMR data showed that a large chemical-shift perturbation was observed upon conversion from the TAP–DEP Michaelis complex into the tetrahedral complex. The amide protons of Ser10 and Gly44 act as proton donors in the oxyanion hole, which stabilize the tetrahedral adduct. X-ray crystallography of TAP–DEP identified that Asn73 offers its Hδ for hydrogen-bonding to the oxyanion [25] (Figure 5). The mutants G44A and N73A were analysed using the same substrates as the kinetic study.
G44A
In response to NPB, G44A retained a kcat value that was 21% of the wild-type enzyme and had little change in the Km value. The significant reduction in the kcat activity (3.16±0.08 s−1 compared with 15.29±0.79 s−1 for the wild-type) was caused by the methyl group of the alanine residue replacing the Hα of Gly44, which indicates that the heavier side chain disturbed tetrahedral-intermediate formation, but had little effect on accessibility of the substrate. For substrates C12-CoA and L-NBTNPE, the decreased Km values gave further assurance that replacing the target residue with alanine did not handicap the substrate binding. The reduced catalytic efficiency in response to C12-CoA and L-NBTNPE was predominantly caused by the reduced kcat activity (only 7.6 and 8.7% compared with the wild-type activity respectively).
The crystal structure comparison of both native TAP and TAP–DEP complex revealed no difference in the position of Gly44 (shown in Figure 5, inset). They could actually be superimposed using Gly44 and the nearby residues, with the exception of the unique side chain of Ser43 (Figure 5 inset). The angles, ϕ and ψ, of Ser43 in the TAP and the TAP–DEP structures are: ϕ −64.47° and ψ 140.07°, and ϕ −54.41° and ψ 134.47° respectively. However, the side chain of Ser43 is too distant to form any hydrogen-bonding with the DEP molecule in TAP–DEP structure.
It is proposed that the conversion from the TAP–DEP Michaelis complex into the tetrahedral complex involves Gly44 movement, and that the movement of Gly44 also draws on the movements of the neighbouring residues. Glycine has the most freely rotatable Cα ϕ and ψ angles among the 20 amino acid residues in the protein folding structure, and that is due to the presence of the smallest side chain, hydrogen. The significant alteration of the Ser43 side chain position and the highly decreased kcat of G44A (in response to all three substrates) suggests that the less restrained movement of Gly44 is important in conformational fine-tuning during oxyanion formation.
N73A
N73A retained 78% of kcat activity and had a Km that was approx. 2-fold greater compared with the wild-type TAP in response to NPB. Nevertheless, its kcat activity was reduced to approx. one-tenth of the wild-type activity in response to C12-CoA and L-NBTNPE (11.3 and 8.8% respectively), and also had decreased Km values (0.58- and 0.25-fold compared with the wild-type respectively). The hydrophilic amide side chain of Asn73 obviously had decreased accessibility for hydrophobic substrates (C12-CoA and L-NBTNPE), because lower Km values were observed when this residue was replaced with an alanine residue. In contrast, the smallest and most hydrophilic substrate, NPB, increased its Km value 1.91-fold in response to the N73A mutation.
In SGNH-hydrolases, the oxyanion hole has three hydrogen-bond donors. In TAP, the three proton donors are Ser10 and Gly44 with amide protons, and Asn73 with Hδ (Figure 5). No striking decline in the catalytic efficiency of the N73A mutant compared with the wild-type was observed. As Asn73 is considered to provide one-third of the hydrogen-bonding contribution to the stabilization of the oxyanion, thus the lower activity of the N73A mutant is proposed to be due to the remaining two-thirds of the hydrogen-bonding from the Ser10 and Gly44 residues. The lowest activity in response to C12-CoA (19%), a long fatty-acyl substrate, indicates that fatty-acyl substrate is predominantly affected compared with the other two substrates. Asn73 is close to the switch loop75–80 that was recently reported to show a remarkable conformational change in the crystal structure of TAP-OCA (native TAP soaked with octanoic acid; PDB code 1U8U) [27], which indicated that Asn73 was capable of accommodating longer acyl-chain-length substrates. Although the position of Asn73 in both the TAP and TAP-OCA structures is consistent, the function for longer-acyl substrate accommodation by loop75–80 is considered to be correlated with the Asn73 residue. We propose that the role of Asn73 is also involved in the loop75–80 switch-move motion, and is therefore more essential for accommodation of longer acyl-chain-length substrates.
Conclusions
The catalytic triad Ser10-Asp154-His157, as well as the oxyanion-stabilizing residues Gly44 and Asn73, of the TAP enzyme were mutated to evaluate their roles in catalytic behaviour. Of the residues, His157 is the most important as it plays a vital role in the catalytic triad, and may also be devoted to stabilizing the oxyanion-intermediate conformation. Ser10 is a very important residue in the mechanism and a water molecule can, at best, act as a poor replacement. The water molecule could possibly possess the nucleophilic-attacking character that is endowed by His157 hydrogen-bonding. Asp154 is not essential compared with the other residues in the catalytic triad. It is located close to the entrance of the substrate tunnel, therefore it predominantly affects substrate accessibility. The effect of Asp154 withdrawal of His157 is proposed to provide a larger active cleft, which would allow the accommodation of bigger substrates. Gly44 plays a role in the stabilization of the oxyanion intermediate. The side-chain position of Ser43 in TAP–DEP differed from that of the native TAP, and the reduced kcat values observed for the G44A mutant in response to the three substrates suggests that Gly44 is also involved in accommodating the acyl-enzyme-intermediate transformation. N73A showed the highest residual enzyme activity among all of the mutants, which indicates that Asn73 is not as essential in the catalytic process as the other mutated residues.
Acknowledgments
We are grateful to Dr K. C. Tsai in the Genomics Research Centre, Academia Sinica, Taiwan, for plot production. We thank the computer modelling training course provided by National Centre for High-Performance Computing, Hsinchu Science Park, Hsinchu 30076, Taiwan. This work was supported by a grant [National Science and Technology Programme for Agricultural Biotechnology (23-71)] to J.-F.S., and a grant (NSC 92-2311-B-030-002) to Y.-L.L. from the National Science Council, Republic of China.
References
- 1.Klibanov A. M. Asymmetric transformations catalyzed by enzymes in organic solvents. Acc. Chem. Res. 1990;23:114–120. [Google Scholar]
- 2.Gandhi N. N. Applications of lipase. J. Am. Oil Chem. Soc. 1997;74:621–634. [Google Scholar]
- 3.Upton C., Buckley J. T. A new family of lipolytic enzymes? Trends Biochem. Sci. 1995;20:178–179. doi: 10.1016/s0968-0004(00)89002-7. [DOI] [PubMed] [Google Scholar]
- 4.Molgaard A., Kauppinen S., Larsen S. Rhamnogalacturonan acetylesterase elucidates the structure and function of a new family of hydrolases. Structure. 2000;8:373–383. doi: 10.1016/s0969-2126(00)00118-0. [DOI] [PubMed] [Google Scholar]
- 5.Li J., Derewenda U., Dauter Z., Smith S., Derewenda Z. S. Crystal structure of the Escherichia coli thioesterase II, a homolog of the human Nef binding enzyme. Nat. Struct. Biol. 2000;7:555–559. doi: 10.1038/76776. [DOI] [PubMed] [Google Scholar]
- 6.Akoh C. C., Lee G. C., Liaw Y. C., Huang T. H., Shaw J. F. GDSL family of serine esterases/lipases. Prog. Lipid Res. 2004;43:534–552. doi: 10.1016/j.plipres.2004.09.002. [DOI] [PubMed] [Google Scholar]
- 7.Shaw J. F., Chang R. C., Chuang K. H., Yen Y. T., Wang Y. J., Wang F. G. Nucleotide sequence of a novel arylesterase gene from Vibro mimicus and characterization of the enzyme expressed in Escherichia coli. Biochem. J. 1994;298:675–680. doi: 10.1042/bj2980675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Chang R. C., Chen J. C., Shaw J. F. Site-directed mutagenesis of arylesterase from Vibrio mimicus identifies residues essential for catalysis. Biochem. Biophys. Res. Commun. 1996;221:477–483. doi: 10.1006/bbrc.1996.0620. [DOI] [PubMed] [Google Scholar]
- 9.Lee Y. L., Chen J. C., Shaw J. F. The thioesterase of Escherichia coli has arylesterase activity and shows stereospecificity for protease substrates. Biochem. Biophys. Res. Commun. 1997;231:452–456. doi: 10.1006/bbrc.1997.5797. [DOI] [PubMed] [Google Scholar]
- 10.Lee Y. L., Su M. S., Huang T. H., Shaw J. F. C-terminal His-tagging results in substrate specificity changes of the thioesterase I from Escherichia coli. J. Am. Oil Chem. Soc. 1999;76:1113–1118. [Google Scholar]
- 11.Cho H., Cronan J. E., Jr Escherichia coli thioesterase I, molecular cloning and sequencing of the structural gene and identification as a periplasmic enzyme. J. Biol. Chem. 1993;268:9238–9245. [PubMed] [Google Scholar]
- 12.Pacaud M., Uriel J. Isolation and some properties of a proteolytic enzyme from Escherichia coli (protease I) Eur. J. Biochem. 1971;23:435–442. doi: 10.1111/j.1432-1033.1971.tb01638.x. [DOI] [PubMed] [Google Scholar]
- 13.Albright F. R., White D. A., Lennarz W. J. Studies on enzymes involved in the catabolism of phospholipids in Escherichia coli. J. Biol. Chem. 1973;248:3968–3977. [PubMed] [Google Scholar]
- 14.Doi O., Nojima S. Lysophospholipase of Escherichia coli. J. Biol. Chem. 1975;250:5208–5214. [PubMed] [Google Scholar]
- 15.Pacaud M., Sibilli L., LeBras G. Protease I from Escherichia coli. Eur. J. Biochem. 1976;69:141–151. doi: 10.1111/j.1432-1033.1976.tb10867.x. [DOI] [PubMed] [Google Scholar]
- 16.Karasawa K., Kudo I., Kobayashi T., Homma H., Chiba N., Mizushima H., Inove K., Nojima S. Lysophospholipase L1 from Escherichia coli K-12 overproducer. J. Biochem. 1991;109:288–293. [PubMed] [Google Scholar]
- 17.Ichihara S., Matsubara Y., Kato C., Akasaka K., Mizushima S. Molecular cloning, sequencing, and mapping of the gene encoding protease I and characterization of proteinase and proteinase-defective Escherichia coli mutants. J. Bacteriol. 1993;175:1032–1037. doi: 10.1128/jb.175.4.1032-1037.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cho H., Cronan J. E., Jr ‘Protease I’ of Escherichia coli functions as a thioesterase in vivo. J. Bacteriol. 1994;176:1793–1795. doi: 10.1128/jb.176.6.1793-1795.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lin T. H., Chen C., Haung R. F., Lee Y. L., Shaw J. F., Huang T. H. Multinuclear NMR resonance assignments and the secondary structure of Escherichia coli thioesterase/protease I: a member of a new subclass of lipolytic enzymes. J. Biomol. NMR. 1998;11:363–380. doi: 10.1023/a:1008226515482. [DOI] [PubMed] [Google Scholar]
- 20.Huang Y. T., Liaw Y. C., Gorbatyuk V. Y., Huang T. H. Backbone dynamics of Escherichia coli thioesterase/protease I: evidence of a flexible active-site environment for a serine protease. J. Mol. Biol. 2001;307:1075–1090. doi: 10.1006/jmbi.2001.4539. [DOI] [PubMed] [Google Scholar]
- 21.Lo Y. C., Lee Y. L., Shaw J. F., Liaw Y. C. Crystallization and preliminary X-ray crystallographic analysis of thioesterase I from Escherichia coli. Acta Crystallogr. Sect. D: Biol. Crystallogr. 2000;56:756–757. doi: 10.1107/s0907444900004339. [DOI] [PubMed] [Google Scholar]
- 22.Lo Y. C., Lin S. C., Shaw J. F., Liaw Y. C. Crystal structure of Escherichia coli thioesterase I/protease I/lysophospholipase L1: consensus sequence blocks constitute the catalytic centre of SGNH-hydrolases through a conserved hydrogen bond network. J. Mol. Biol. 2003;330:539–551. doi: 10.1016/s0022-2836(03)00637-5. [DOI] [PubMed] [Google Scholar]
- 23.Tanksley S. D., Orton T. T. East Linn: Elsevier Science Publishers; 1983. Isozymes in Plant Genetics and Breeding, Part A. [Google Scholar]
- 24.Blank A., Sugiyama R. H., Deffer C. A. Activity staining of nucleolytic enzymes after sodium dodecyl sulphate-polyacrylamide gel electrophoresis: use of aqueous isopropanol to remove detergent from gels. Anal. Biochem. 1982;120:267–275. doi: 10.1016/0003-2697(82)90347-5. [DOI] [PubMed] [Google Scholar]
- 25.Tyukhtenko S. I., Litvinchuk A. V., Chang C. F., Lo Y. C., Lee S. J., Shaw J. F., Liaw Y. C., Huang T. H. Sequential structural changes of Escherichia coli thioesterase/protease I in the serial formation of Michaelis and tetrahedral complexes with diethyl p-nitrophenyl phosphate. Biochemistry. 2003;42:8289–8297. doi: 10.1021/bi027246w. [DOI] [PubMed] [Google Scholar]
- 26.Benning M. M., Wesenberg G., Liu R., Taylor D. L., Dunaway-Marianos D., Holden H. M. The three-dimensional structure of 4-hydroxybenzoyl-CoA thioesterase from Pseudomonas sp. strain CBS-3. J. Biol. Chem. 1998;273:33572–33579. doi: 10.1074/jbc.273.50.33572. [DOI] [PubMed] [Google Scholar]
- 27.Lo Y. C., Lin S. C., Shaw J. F., Liaw Y. C. Substrate specificities of Escherichia coli thioesterase I/protease I/lysophospholipase L1 are governed by its switch loop movement. Biochemistry. 2005;44:1971–1979. doi: 10.1021/bi048109x. [DOI] [PubMed] [Google Scholar]